Skye Bioscience

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SKYE and other ETFs, options, and stocks.

About SKYE

Skye Bioscience, Inc. is a clinical stage biopharmaceutical company, which engages in the business of research and development activities related to developing medicine for obesity and metabolic diseases. Its products include nimacimab and SBI-100 Ophthalmic Emulsion. 

CEO
Punit S. Dhillon
CEOPunit S. Dhillon
Employees
12
Employees12
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2011
Founded2011
Employees
12
Employees12

SKYE Key Statistics

Market cap
4.38M
Market cap4.38M
Price-Earnings ratio
-0.10
Price-Earnings ratio-0.10
Dividend yield
—
Dividend yield—
Average volume
25.23K
Average volume25.23K
High today
$1.09
High today$1.09
Low today
$0.9801
Low today$0.9801
Open price
$1.09
Open price$1.09
Volume
14.17K
Volume14.17K
52 Week high
$12.80
52 Week high$12.80
52 Week low
$0.9801
52 Week low$0.9801

Stock Snapshot

As of today, Skye Bioscience(SKYE) shares are valued at $0.99. The company's market cap stands at 4.38M, with a P/E ratio of -0.10.

As of 2026-11-06, Skye Bioscience(SKYE) stock has fluctuated between $0.98 and $1.09. The current price stands at $0.99, placing the stock +1.0% above today's low and -9.2% off the high.

The Skye Bioscience(SKYE)'s current trading volume is 14.17K, compared to an average daily volume of 25.23K.

During the past year, Skye Bioscience(SKYE) stock moved between $0.98 at its lowest and $12.80 at its peak.

During the past year, Skye Bioscience(SKYE) stock moved between $0.98 at its lowest and $12.80 at its peak.

People also own

Based on the portfolios of people who own SKYE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.